John Mumm, Ph.D.
Affiliations: | 2005 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
ImmunologyGoogle:
"John Mumm"Parents
Sign in to add mentorElizabeth A. Grimm | grad student | 2005 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
(IL -24; a glycosylated dimeric cytokine affecting monocytes and cytotoxic to melanoma cells.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang Y, Mumm JB, Herbst R, et al. (2017) IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression. Journal of Immunology (Baltimore, Md. : 1950) |
Chan IH, Wu V, Bilardello M, et al. (2016) PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDO. Oncoimmunology. 5: e1197458 |
Naing A, Papadopoulos KP, Autio KA, et al. (2016) Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology |
Papadopoulos KP, Naing A, Infante JR, et al. (2016) Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with pancreatic or colorectal cancer. Journal of Clinical Oncology. 34: 3082-3082 |
Naing A, Papadopoulos KP, Infante JR, et al. (2016) Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1. Journal of Clinical Oncology. 34: 3018-3018 |
Naing A, Infante JR, Papadopoulos KP, et al. (2016) Abstract PR08: Antitumor activity and immune correlates of PEGylated human IL-10 (AM0010) alone or in combination with anti-PD-1 Cancer Immunology Research. 4 |
Chan IH, Wu V, McCauley S, et al. (2015) IL-10: Expanding the Immune Oncology Horizon. Receptors & Clinical Investigation. 2 |
Chan IH, Wu V, Bilardello M, et al. (2015) The Potentiation of IFN-γ and Induction of Cytotoxic Proteins by Pegylated IL-10 in Human CD8 T Cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research |
Chan IH, Jain R, Tessmer MS, et al. (2014) Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunology. 7: 842-56 |
Mumm JB, Oft M. (2013) Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicity. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 35: 623-31 |